Join our team
Associate Scientist/ Scientist I/ II – Analytical Development

Job Responsibilities:

  • Develop, optimize and perform a broad range of biochemical and cell-based assays for the characterization of therapeutic antibodies, including but not limited immunoassay, Real-Time PCR, Flow Cytometry, Western Blot and other protein analysis
  • Culture mammalian cells, insect cells and immune cells (lymphocytes, NK cells, dendritic cells, PBMC, ) for required experimental objectives.
  • Participate and drive assay development, assay transfer and assay qualification activities within department and CRO
  • Compile analytical data, perform data analysis and interpretation, prepare technical report, present data to project teams, give oral presentation at internal or external meetings.
  • Troubleshoot method and instrumentation problems; be proactive in solving technical problems.
  • Effectively plan and ensure project deliverables and timelines are met and contribute to mentoring and training team members
  • Excellent oral and written communication skills; highly organized and efficient record keeping

Job Requirements:

Master or Ph.D’s degree in Biochemistry, Cell Biology, Molecular Biology or related discipline with a minimum of 2 years’ industry laboratory or 5 years’ academic research experience

  • Experience with aseptic techniques, cell culture (suspension and adherent), cell-based potency assays, ELISAs and molecular biology techniques (PCR/qPCR) is preferred
  • Strong hands-on experience with the development and qualification of luminescence/fluorometry/colorimetry-based assays
  • Strong ability to multi-task and willingness to work effectively in highly collaborative and diverse environment.
  • Demonstrated track record of completing tasks within established timelines
  • Data processing skills using Windows based software (Excel, Softmax Pro, GraphPad Prizm, etc.)
  • Strong aptitude to work collaboratively with internal and external partners
For more information, please see: Job Post_AS_XLZ 2019-12-02.pdf
November 21, 2019 Back